Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

NCT00244725 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00244725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2006
Enrollment
961 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, fibrillation, atrial, pulmonary embolism, venous thromboembolism